KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Work In Process: 2011-2024

Historic Work In Process for Halozyme Therapeutics (HALO) over the last 14 years, with Dec 2024 value amounting to $30.2 million.

  • Halozyme Therapeutics' Work In Process rose 134.05% to $34.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.8 million, marking a year-over-year increase of 134.05%. This contributed to the annual value of $30.2 million for FY2024, which is 11.33% down from last year.
  • Latest data reveals that Halozyme Therapeutics reported Work In Process of $30.2 million as of FY2024, which was down 11.33% from $34.0 million recorded in FY2023.
  • In the past 5 years, Halozyme Therapeutics' Work In Process registered a high of $44.1 million during FY2022, and its lowest value of $17.5 million during FY2021.
  • For the 3-year period, Halozyme Therapeutics' Work In Process averaged around $36.1 million, with its median value being $34.0 million (2023).
  • As far as peak fluctuations go, Halozyme Therapeutics' Work In Process plummeted by 48.27% in 2021, and later soared by 152.72% in 2022.
  • Over the past 5 years, Halozyme Therapeutics' Work In Process (Yearly) stood at $33.7 million in 2020, then plummeted by 48.27% to $17.5 million in 2021, then soared by 152.72% to $44.1 million in 2022, then dropped by 22.85% to $34.0 million in 2023, then dropped by 11.33% to $30.2 million in 2024.